Jeffrey M Leiden
Director; Director, Executive Chairman · 4 filings · Latest: May 7, 2026
Odyssey Therapeutics, Inc.
VERTEX PHARMACEUTICALS INC / MA
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ODTX | Jeffrey M Leiden | Director | May 11, 2026 | Option Exercise | — | 2,963 | — | 31,661 | |
ODTX | Jeffrey M Leiden | Director | May 8, 2026 | Purchase | $20.00 | 5,000 | $100.0K | 270,198 | |
VRTX | JEFFREY M LEIDEN | — | Dec 3, 2025 | Proposed Sale | $433.15 | 63,781 | $27.6M | — | |
VRTX | JEFFREY M LEIDEN | — | Nov 14, 2025 | Proposed Sale | $434.52 | 53,604 | $23.3M | — | |
VRTX | JEFFREY M LEIDEN | — | Nov 13, 2025 | Proposed Sale | $434.19 | 19,688 | $8.5M | — | |
VRTX | JEFFREY LEIDEN | — | Aug 30, 2024 | Proposed Sale | $493.35 | 3,784 | $1.9M | — |